"A detailed probe into the spurious drug 'Amoxicillin Trihydrate', IP batch No PBT-1583, supplied to the Health institutions in the state was referred to the Crime Branch," Health Minister Shabir Ahmad Khan told reporters here.
"The matter has also been referred to the Vigilance Department to ascertain the role of various officials involved," he said.
"The Drug Control Department through its testing laboratory revealed that Amoxicillin Trihydrate, manufactured in August 2012 and supplied by M/S Life Line Pharmaco Surgical, has zero potency and, hence, failed the test," the Minister said.
These spurious medicines to the tune of Rs 11.23 lakh were supplied to the government, Khan said.
When asked about the involvement of former Health Minister Sham Lal Sharma in the scam and whether the inquiry committee, set up by the state government, had indicted him, the Minister said "no".
Further inquiries would be conducted by the Crime Branch and the Vigilance Department, Khan said.
The inquiry committee, which was set up by the state government on April 4 to submit a report within 15 days, did not indict former Health Minister and present PHE, Irrigation and Flood Control minister Sham Lal Sharma.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
